Fetomaternal Haemorrhage

The challenge 

The laboratory scientist’s role in estimating Fetomaternal Haemorrhage (FMH) requires a deep understanding of competing methodologies and the skill to interpret complex data. Without standardised expertise, a scientist may struggle to select the appropriate test or correctly manage ambiguous results. In such situations, there is a significant risk that their clinical advice will be flawed, leading to inadequate treatment and severe consequences for future pregnancies.

The solution

A digital learning program that helps laboratory scientists to:

• Identify the specific clinical scenarios that require an FMH estimation to be performed
• Evaluate the different testing methodologies, from standard calculations to advanced flow cytometry, understanding the advantages and limitations of each
• Accurately interpret and manage complex FMH results, navigating potential discrepancies and ambiguous findings
• Translate laboratory results into clear clinical advice, ensuring the correct, evidence-based dose of anti-D immunoglobulin is recommended to the clinical team